Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,950 $ 1,079
Short-term investments 7,857 12,893
Prepaid expenses and other current assets 78 84
Total Current Assets 9,885 14,056
Operating lease right-of-use asset 27 53
TOTAL ASSETS 9,912 14,109
Current liabilities    
Accounts payable 3,213 4,328
Accrued expenses 963 1,195
Current operating lease liability 30 58
Warrant liability 394 1,052
Total Current Liabilities 4,600 6,633
Total Liabilities 4,600 6,633
Stockholders’ Equity    
Convertible Preferred stock,  par value $0.01, 15,000,000 shares authorized Series C - 96,230 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 1 1
Common stock,  par value $0.001, 250,000,000 shares authorized, 1,380,633 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 1 1
Additional paid in capital 689,641 689,539
Accumulated deficit (684,331) (682,065)
Total Stockholders’ Equity 5,312 7,476
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 9,912 $ 14,109